Circulating tumor cells, disease progression, and survival in metastatic breast cancer.
Explore this paper's citation graph
Summary
The number of circulating tumor cells before treatment is an independent predictor of progression-free survival and overall survival in patients with metastatic breast cancer.
- Type
- article
- Published
- 2004-08-19
- Cited by
- 4,434
- References
- 64
- Access
- Open access
- OpenAlex
- https://openalex.org/W2111976640
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:7445998
Keywords
Medicine, Metastatic breast cancer, Breast cancer, Disease, Oncology
References
- Deletional mutant EGFR detected in circulating tumor-derived DNA from lung cancer patients treated with gefitinib.
- DNA chips: An array of possibilities
- Detection of hematogenous micrometastasis in patients with prostate cancer.
- Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.
- Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors.
- Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy.
- Circulating Cancer Cells in Peripheral Blood
- Cancer cells in blood. Results of a simplified isolation technique.
- Tumor angiogenesis: therapeutic implications.
- Reduced T-Cell and Dendritic Cell Function Is Related to Cyclooxygenase-2 Overexpression and Prostaglandin E2 Secretion in Patients With Breast Cancer
- Prognostic significance of occult lymph node metastases in node-negative breast cancer
- Carcinocythemia (carcinoma cell leukemia). Report of two cases with english literature review
- Carcinocythemia (carcinoma cell leukemia). An acute leukemia-like picture due to metastatic carcinoma cells.
- TNM clinical stage classification of breast cancer
- Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).
- Peripheral blood tumor cell load reflects the clinical activity of the disease in patients with carcinoma of the breast.
- Carcinocythemia (carcinoma cell leukemia) due to metastatic carcinoma of the breast. Report of a case
- Occult Metastases in Axillary Lymph Nodes as a Predictor of Survival in Node‐Negative Breast Carcinoma with Long‐term Follow‐up
- Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients
- Detection of micrometastatic cells in breast cancer by RT-pCR for the mammaglobin gene.
Cited by
- Tumor dormancy and metastasis.
- Bone Metastasis of Breast Cancer.
- Small-cell lung cancer: an update on targeted therapies.
- Therapeutic options in the management of metastatic breast cancer.
- [Evolving strategies over time for treatment of breast cancer].
- Molekulare Marker in Diagnostik und Therapie des Urothelkarzinoms
- The measurement and therapeutic implications of circulating tumour cells in breast cancer
- Breast cancer biomarkers.
- Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients.
- Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer.
- Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146
- Circulating tumor cells in the management of breast cancer.
- Particle sorting using a porous membrane in a microfluidic device.
- Detection of tumor cells in the bone offers independent prognostic value in bladder cancer patients: the clinical and basic science perspective.
- Malignant characteristics of circulating tumor cells and corresponding primary tumor in a patient with esophageal squamous cell carcinoma before and after surgery
- The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer
- Detection of apoptotic circulating tumor cells in advanced pancreatic cancer following 5-fluorouracil chemotherapy
- Unbiased and Automated Identification of a Circulating Tumour Cell Definition That Associates with Overall Survival
- NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.
- A Prognostic Gene Expression Profile That Predicts Circulating Tumor Cell Presence in Breast Cancer Patients
Related papers
- Circulating Tumor Cells in Breast Cancer.
- Determination of cut-offs for circulating tumor cell measurement in metastatic cancer
- Circulating tumor cells, disease progression, and survival in metastatic breast cancer.
- USP1 inhibition destabilizes KPNA2 and suppresses breast cancer metastasis
- A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancer
- Abstract P2-08-09: Prognostic values of circulating tumor cell (CTC) enumeration and their clusters in advanced breast cancer